Clinica Baviera S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €43.70 High: €44.10
on August 8, 2025

52 Week Range

Low: €28.30 High: €45.40
on August 8, 2024
on July 16, 2025

All-Time High: €45.40 on July 16, 2025

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €698.2M
EPS i 2.40
P/E Ratio (TTM) i 18.17
Forward P/E i 24.77
P/B Ratio i 7.83
PEG Ratio i 24.77
Div. Yield i 7.97%
ROE i 46.33%
Beta i 0.799
Debt to Equity i 70.72

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i 19.71%
Profit Margin i 13.51%

Returns and Earnings

Return on Assets (TTM) i 16.56%
Return on Equity (TTM) i 46.33%
EBITDA i €80.5M
Net Income (TTM) i €39.0M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €18.07
Quarterly Revenue Growth (YoY) i 12.00%
Quarterly Earnings Growth (YoY) i -9.80%

Dividend Information

Last 12-Month Dividend i €3.14
Current Dividend Yield i 7.97%
3-Year Average Dividend Yield i 4.15%
3-Year Average Annual Dividend i €1.48
3-Year Total Dividends i €4.44
Ex-Dividend Date i June 11, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Clinica Baviera S.A CBAV 698.18M Mid-cap0.69%0.46%17.02%24.29%39.68%53.31%113.59%394.38%
Pangaea Oncology PANG 58.60M Small-cap0.00%1.78%1.18%-1.71%-2.82%17.01%17.81%59.26%
EuroEspes S.A EEP 6.26M Small-cap0.00%0.00%0.00%0.00%0.00%0.00%3.85%35.00%
Grifols, S.A GRF 7.93B Large-cap-2.06%22.50%57.28%54.08%35.84%46.52%-6.61%-47.55%
Laboratorios ROVI 2.72B Large-cap-2.03%-3.37%3.41%-4.32%-17.03%-32.16%1.36%86.38%
Almirall S.A ALM 2.20B Large-cap-3.21%-4.12%0.20%13.15%22.20%14.03%4.28%7.11%

Ownership & Short Interest

Insider Ownership i 85.09%
Institutional Ownership i 5.55%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 6K
Average 90-Day Volume i 7K

Clinica Baviera S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Clinica Baviera S.A would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Clinica Baviera S.A reached a high of €45.40 (on July 16, 2025) and a low of €28.30 (on August 8, 2024).
Curious about Clinica Baviera S.A's size and valuation? Its market capitalization stands at 698.18M. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.17, and the forward P/E (looking ahead) is 24.77.
Yes, Clinica Baviera S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 7.97%, and the company has paid an average of €1.48 per share annually over the past 3 years.

When looking at Clinica Baviera S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Pangaea Oncology
PANG
58.60MHealthcareDiagnostics & Research17.01%17.81%
EuroEspes S.A
EEP
6.26MHealthcareDiagnostics & Research0.00%3.85%
Grifols, S.A
GRF
7.93BHealthcareDrug Manufacturers - General46.52%-6.61%
Laboratorios
ROVI
2.72BHealthcareDrug Manufacturers - Specialty & Generic-32.16%1.36%
Almirall S.A
ALM
2.20BHealthcareDrug Manufacturers - Specialty & Generic14.03%4.28%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Clinica Baviera S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 46.33%, the Debt to Equity ratio from the most recent quarter is 70.72, and its Gross Profit Margin stands at N/A.
Looking at Clinica Baviera S.A's growth, its revenue over the trailing twelve months (TTM) was €289M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.00%, and quarterly earnings saw a YoY growth of -9.80%.
Wondering who owns Clinica Baviera S.A stock? Company insiders (like executives and directors) hold about 85.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.55%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.